My thoughts:
As we saw during COVID, it’s very important that we improve our pharmaceutical manufacturing and medical supply chains here in Canada. I also see this as a reason why an extensive national pharmacare plan is important. Countries that have implemented such programs have been able to negotiate better deals for the drugs by acting as a single unit instead of many smaller provincial and private organizations. Instead of cutting healthcare services, we could stop paying unreasonably high prices on pharmaceuticals.
Finally, maybe it’s time that Canada reevaluated some of the IP protections that american pharmaceutical companies get.
Were over 10% of US population and we happen to sell 1% of their drugs. We’re about 1% of developed world too, but our proximity would be normal to contribute more. Point is, if there is nothing unfair about the arrangement/supply why turn everything upside down. I’m sure US companies rely on Canadian market too.